R. Dekhuijzen (Nijmegen, The Netherlands), M. Rudolf (Southall, United Kingdom)
Pre-screening test for chronic obstructive pulmonary disease (COPD) using an 11-item questionnaire for elderly subjects
K. Kida, R. Wakabayashi, T. Mizuuchi, H. Katsura, K. Yamada, T. Motegi, N. Nishimura, M. Omata, R. Goto, S. Mizuno (Tokyo, Japan)
|  |
Nutritional state affects central drive and exercise tolerance in patients with COPD
L. Yingxiang, W. Chen (Beijing, China)
| |
Vitamin C, VIP (vasoactive intestinal polypeptide) and gastrin in the serum of COPD patients in stable state and during exacerbation
L. Corkovic, N. Kostic, D. Begovic, L. Nagorni-Obradovic, S. Ignjatovic (Belgrade, Kragujevac, Yugoslavia)
| |
Insulin-like growth factor-I (IGF-I) in COPD exacerbation
P. Kythreotis, P. Bakakos, N. Lolis, E. Ablianitis, A. Kokkini, D. Veldekis, A. Hadjiioannou, A. Rasidakis (Athens, Greece)
| |
Serum leptin levels in patients with chronic obstructive pulmonary disease
M. Calikoglu, G. Sahin, A. Unlu, B. Ercan, L. Tamer, A. Kanik (Mersin, Turkey)
| |
National program of early diagnosis and prevention of COPD
D. Górecka, M. Bednarek, A. Nowinski, R. Plywaczewski, P. Sliwinski, J. Zielinski (Warsaw, Poland)
| |
Impact of standardized admission orders on screening for corticosteroid-induced hyperglycemia in patients hospitalized with an acute exacerbation of COPD
M. Laryea, A. McGibbon, C. P. McParland, P. Hernandez (Halifax, Canada)
| |
The relationship of alpha1-antitripsin level with the dynamics of free and peptide-binded oxyproline in COPD progression
A. E. Makarevich (Minsk, Belarus)
| |
The results of alpha-1 antitrypsine (AAT) phenotyping in patients with COPD
A. Ilic, B. Milenkovic, V. Petrovic (Belgrade, Yugoslavia)
| |
Alpha-1-antitrypsin deficiency patients (AATD): two-year follow-up
B. Lara, M. Miravitlles, S. Vilà, C. de la Roza, I. Garca-Talavera, P. P. España, J. C. Barros-Tizón, A. Bustamante, R. Vidal (Barcelona, Spain)
| |
The ability to taste the bitter of phenylthiocarbamide (PTC) in patients with chronic obstructive pulmonary disease (COPD) and chronic non-obstructive bronchitis (CNOB)
N. Hodgaynce, T. Ivtchik, A. Kokosov, E. Iantchina, L. Karlova, E. Kiseleva, E. Docenko (St-Petersburg, Russia)
| |
Haptoglobin (Hp) phenotypes and smoking history in chronic obstructive pulmonary disease (COPD)
E. Iantchina, T. Ivtchik, A. Kokosov, N. Hodgaynce, L. Karlova, E. Kiseleva (St-Petersburg, Russia)
| |
Acute exacerbation of COPD-the rate of hospital admission
Z. M. Lazic, S. D. Mojsilovic, O. M. Gajovic (Kragujevac, Yugoslavia)
| |
Presence of bacterial infection influences the severity of symptoms in acute COPD exacerbations
B. S. Gvozdenovic, V. Bosnjak-Petrovic (Belgrade, Yugoslavia)
| |
Screening the general population for lung function abnormalities: yield of respiratory symptoms
N. Roche, F. Neukirch, A. Vergnenègre, G. Brahmi, G. Huchon (Paris, France)
| |
Frequency of correct inhalation technique in patients with chronic opstructive pulmonary diseases
L. Nagorni-ObradoviĆ, V. PetroviĆ, M. MitiĆ-MilikiĆ (Belgrade, Yugoslavia)
| |
Molecular-biological markers of hereditary COPD, respiratory oxalosis (RO)
G. Pospekhova, V. Vakharlovsky, M. Mkheidze, L. Guleva, O. Voronina, A. Totolyan (St-Petersburg, Russia)
| |
Pyrogenal plus aprotinin therapy of COPD patients with immune reactivity depression
A. E. Makarevich (Minsk, Belarus)
| |
Effects of air pollution on spirometry pattern in three locations of northern Poland
R. Ucinska, A. Judin, B. Cynowska, L. Wolska-Goszka, J. M. Somiński (Gdansk, Poland)
| |
Late ventricular potentials in detecting sudden death in patients with COPD
M. I. Carjea (Brad, Romania)
| |